STACEY GREENWELL-OSBORNE: Open Payments
NPI 1356809768 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 37 payments from 13 companies in 2025. Trend: 2023 $481 · 2024 $677 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $156 |
| ABBVIE INC. | 6 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $105 |
| Novo Nordisk Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: CAPLYTA, NURTEC ODT, UBRELVY, PREVNAR 20, ELIQUIS, Auvelity, MOUNJARO, VRAYLAR.
Industry payments across KY — which companies pay providers there.
